TNFSF10 and myeloid leukemia: Our findings indicate that Med potentiates TRAIL-induced apoptosis in myeloid leukemia cells by downregulating cell survival proteins, upregulating cell death proteins, and inducing DR5 expression through the activation of the ROS-JNK-CHOP pathway.